EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement

Michele Fusaroli, Francesco Salvo, Bernard Begaud, Thamir M AlShammari, Andrew Bate, Vera Battini, Andreas Brueckner, Gianmario Candore, Carla Carnovale, Salvatore Crisafulli, Paola Maria Cutroneo, Charles Dolladille und 22 weitere

Drug Safety · 2024-06 · 47 (6) · 575-584

DOI: 10.1007/s40264-024-01421-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Safety, online erschienen am 07.05.2024. Verfasst von Michele Fusaroli und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Pharmacovigilance, Adverse Drug Reaction Reporting Systems, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 311-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Open access funding provided by Alma Mater Studiorum - Università di Bologna within the CRUI-CARE Agreement.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: Disproportionality analyses using reports of suspected adverse drug reactions are the most commonly used quantitative methods for detecting safety signals in pharmacovigilance. However, their methods and results are generally poorly reported in published articles and existing guidelines do not capture the specific features of disproportionality analyses. We here describe the development of a guideline (REporting of A Disproportionality analysis for drUg Safety signal detection using individual case safety reports in PharmacoVigilance [READUS-PV]) for reporting the results of disproportionality analyses in articles and abstracts. METHODS: We established a group of 34 international experts from universities, the pharmaceutical industry, and regulatory agencies, with expertise in pharmacovigilance, disproportionality analyses, and assessment of safety signals. We followed a three-step process to develop the checklist: (1) an open-text survey to generate a first list of items; (2) an online Delphi method to select and rephrase the most important items; (3) a final online consensus meeting. RESULTS: Among the panel members, 33 experts responded to round 1 and 30 to round 2 of the Delphi and 25 participated to the consensus meeting. Overall, 60 recommendations for the main body of the manuscript and 13 recommendations for the abstracts were retained by participants after the Delphi method. After merging of some items together and the online consensus meeting, the READUS-PV guidelines comprise a checklist of 32 recommendations, in 14 items, for the reporting of disproportionality analyses in the main body text and four items, comprising 12 recommendations, for abstracts. CONCLUSIONS: The READUS-PV guidelines will support authors, editors, peer-reviewers, and users of disproportionality analyses using individual case safety report databases. Adopting these guidelines will lead to more transparent, comprehensive, and accurate reporting and interpretation of disproportionality analyses, facilitating the integration with other sources of evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacovigilanceAdverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsHumansDelphi TechniqueChecklistConsensusGuidelines as Topic

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
  • Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France.
  • Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM, U1219, 33000, Bordeaux, France.
  • College of Pharmacy, Almaarefa University, Riyadh, Saudi Arabia.
  • Global Safety, GSK, Brentford, UK.
  • Department of Non-Communicable Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Förderung

  • Open access funding provided by Alma Mater Studiorum - Università di Bologna within the CRUI-CARE Agreement

Zitieren

APA

Fusaroli, M., Salvo, F., Begaud, B., AlShammari, T. M., Bate, A., Battini, V., Brueckner, A., Candore, G., Carnovale, C., Crisafulli, S., Cutroneo, P. M., Dolladille, C., Drici, M. D., Faillie, J. L., Goldman, A., Hauben, M., Herdeiro, M. T., Mahaux, O., Manlik, K., …, & Khouri, C. (2024). The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement. Drug Safety, 47(6), 575-584. https://doi.org/10.1007/s40264-024-01421-9

Vancouver

Fusaroli M, Salvo F, Begaud B, AlShammari TM, Bate A, Battini V, et al. The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement. Drug Safety. 2024;47(6):575-584. doi:10.1007/s40264-024-01421-9

BibTeX
@article{Fusaroli2024,
  author = {Fusaroli, Michele and Salvo, Francesco and Begaud, Bernard and AlShammari, Thamir M and Bate, Andrew and Battini, Vera and Brueckner, Andreas and Candore, Gianmario and Carnovale, Carla and Crisafulli, Salvatore and Cutroneo, Paola Maria and Dolladille, Charles and Drici, Milou-Daniel and Faillie, Jean-Luc and Goldman, Adam and Hauben, Manfred and Herdeiro, Maria Teresa and Mahaux, Olivia and Manlik, Katrin and Montastruc, François and Noguchi, Yoshihiro and Norén, G Niklas and Noseda, Roberta and Onakpoya, Igho J and Pariente, Antoine and Poluzzi, Elisabetta and Salem, Myriam and Sartori, Daniele and Trinh, Nhung T H and Tuccori, Marco and van Hunsel, Florence and van Puijenbroek, Eugène and Raschi, Emanuel and Khouri, Charles},
  title = {The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement},
  journal = {Drug Safety},
  year = {2024},
  volume = {47},
  number = {6},
  pages = {575--584},
  doi = {10.1007/s40264-024-01421-9}
}
Kostenlos starten →